Max Healthcare Institute Ltd. announces a new order win

The 400-bed Saket tower’s project-specific capex cannot be established from the cited disclosures. The reported figure of Rs 1,485 Crores in FY26 is Max Healthcare’s consolidated company-wide capex, not the amount incurred for the Saket tower alone ^[1].

Accordingly, it would be incorrect to attribute the full Rs 1,485 Crores to the tower or to treat it as a direct reconciliation against Saket guidance. The consolidated capex had been Rs 966 Crores in FY25, but this year-on-year increase also covers other hospitals, maintenance and expansion projects across the group ^[1]. Consolidated capital work in progress was Rs 592 Crores at FY26 year-end, versus Rs 900 Crores in FY25; this balance likewise cannot isolate the Saket project or represent its cumulative cost ^[2].

Reconciliation: a numerical comparison with Saket’s capex guidance cannot be completed because the project-level incurred amount and the corresponding guidance figure are not reported in the cited material. The correct conclusion is therefore:

• Company-wide FY26 capex: Rs 1,485 Crores ^[1]
• Saket tower capex incurred: not separately disclosed
• Saket-specific guidance: not available in the cited investor-presentation or annual-report evidence
• Reconciliation: not determinable without project-level disclosure

The 400-bed tower increases Saket’s capacity from approximately 800 beds to 1,200 beds. On the post-expansion base, the new tower represents approximately 33.33% of total capacity, while the existing facility accounts for the remaining 66.67%. This is a derived capacity mix from the company’s stated 1,200-bed total and 400-bed addition; it implies a roughly 50% increase over the pre-expansion base. ^[3]

Ramp-up timeline

The 3 September 2026 company update does not state a timeline for filling the new beds, nor does it provide a target date or occupancy threshold for reaching optimal utilisation. It confirms the tower’s inauguration and capacity addition, but not the pace of operational ramp-up. ^[3]

Accordingly, the near-term effect is clear in capacity terms, but the revenue and utilisation impact remains dependent on the undisclosed ramp-up curve, including commissioning, staffing, patient acquisition and occupancy progression.

The 400-bed Saket tower is a meaningful step toward Max Healthcare’s broader Delhi-NCR capacity ambition, but the exact percentage progress cannot be calculated because the previously disclosed cluster-wide target and pre-addition Delhi-NCR bed base are not restated in the current disclosure.

• Capacity impact: The addition raises Max Saket’s total capacity to approximately 1,200 beds, implying a reported 400-bed increase at the facility. ^[3]
• Strategic relevance: Saket is positioned as a major tertiary and quaternary-care hub within Max’s Delhi-NCR ecosystem, alongside facilities in Patparganj, Vaishali, Rajendra Place, Dwarka, Noida and Shalimar Bagh. ^[4]
• Progress toward target: If the earlier Delhi-NCR target is `T` beds, this announcement advances progress by `400 / T`; the remaining requirement would be the earlier gap less 400 beds. The absolute balance and completion percentage remain undisclosed in this filing.
• Analyst implication: This is a concrete execution milestone rather than merely a planned expansion. However, the economic contribution will depend on how quickly the new beds are staffed, occupied and integrated into the hospital’s specialty mix; no ramp-up or utilization guidance was disclosed. The company describes the expansion as strengthening specialised-care access across Delhi-NCR. ^[3]